𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of growth and enhancement of differentiation of colorectal carcinoma cell lines by MAb MR6 and IL-4

✍ Scribed by Abdulhamid A. Al-Tubuly; René Spijker; Massimo Pignatelli; Suzan C. Kirkland; Mary A. Ritter


Publisher
John Wiley and Sons
Year
1997
Tongue
French
Weight
225 KB
Volume
71
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


We have previously shown that expression of gp200-MR6, a molecule that is functionally associated with the interleukin-4 receptor (IL-4R), is lost from breast carcinoma cells as malignancy increases. Here we have analysed a series of colorectal carcinoma cell lines and show a similar decrease with increasing malignancy. Moreover, analysis of the HRA-19 cell line, which can exhibit a poorly or a well-differentiated phenotype according to culture conditions, shows that gp200-MR6 is weakly expressed on the former but strongly expressed on the latter. Functional analysis using either IL-4 or monoclonal antibody (MAb) MR6 and the well-differentiated cell line SW1222 revealed that MAb MR6 acts as an agonist for IL-4, with both reagents causing a dose-dependent inhibition of cell division, but greatly enhancing the glandular differentiation of SW1222 in three-dimensional collagen gels. These observations suggest that the gp200-MR6 molecule may act as the product of a tumour suppressor gene and that its loss may be a primary event in tumourigenesis. Int.


📜 SIMILAR VOLUMES


Clonal growth of colorectal-carcinoma ce
✍ Nico J. De Both; Marcel Vermey; Nicole Groen; Winand N. Dinjens; Fred T. Bosman 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 118 KB 👁 2 views

It is generally assumed that tumor progression is a microevolutionary process in which increasingly aggressive clones, generated through genetic instability, emerge in an initially monoclonal lesion. The present study was undertaken to determine how rapidly a dominant clone will emerge from an initi

Secretion of functional hematopoietic gr
✍ Klaus G. Steube; Corinna Meyer; Hans G. Drexler 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 71 KB 👁 1 views

We studied the constitutive production of hematopoietic cytokines in a large panel of human cell lines originating from a wide variety of solid tumors. Conditioned media (CM) from the carcinoma cell lines were collected and screened for proliferative activity using a bioassay with indicator cell lin

Effects of sodium butyrate on growth, di
✍ Ann Gillenwater; Chang-Ping Zou; Meiling Zhong; Reuben Lotan 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 451 KB 👁 2 views

Background. Biologic agents that reverse early changes in the aerodigestive tract mucosa have potential treatment applications for patients with field cancerization of the upper aerodigestive tract. Sodium butyrate (BA) is a normal dietary constituent that induces differentiation and inhibits growth

Inhibition of intrinsic gap-junction int
✍ Vladimir A. Krutovskikh; Hiroshi Yamasaki; Hiroyuki Tsuda; Makoto Asamoto 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

The tumor-suppressive property of the connexin gap-junction proteins was postulated from the fact that their function of cell coupling is impaired in most cancer cells. However, in conflict with this notion, certain cancer cells are able to communicate through gap junctions despite their malignancy.

Growth inhibition of human pancreatic ca
✍ Kei-ichiro Kita; Seiji Saito,; Cintia Y. Morioka; Akiharu Watanabe 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB 👁 1 views

About 90% of human pancreatic cancers carry K-ras point mutation, which may play an important role in tumorigenesis. We investigated the inhibitory effects of anti-sense oligonucleotides targeting K-ras point mutation on the growth of cultured human pancreatic cancer cells. Eight human pancreatic ca